Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Authors
Keywords
-
Journal
EBioMedicine
Volume 74, Issue -, Pages 103705
Publisher
Elsevier BV
Online
2021-12-01
DOI
10.1016/j.ebiom.2021.103705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV
- (2021) Jake A. Ruddy et al. AIDS
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients – Prospective cohort study
- (2021) Benaya Rozen-Zvi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
- (2021) Liane Rabinowich et al. JOURNAL OF HEPATOLOGY
- COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
- (2021) Lindsey E. Roeker et al. LEUKEMIA
- BNT162b2 COVID ‐19 vaccine is significantly less effective in patients with hematologic malignancies
- (2021) Katrin Herzog Tzarfati et al. AMERICAN JOURNAL OF HEMATOLOGY
- Serological response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS‐CoV‐2
- (2021) Louis Firket et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
- (2021) Lindsey Elizabeth Roeker et al. BLOOD
- Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy
- (2021) Binod Dhakal et al. BLOOD
- The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
- (2021) Bezawit A Woldemeskel et al. CLINICAL INFECTIOUS DISEASES
- Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
- (2021) Ilies Benotmane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
- (2021) David Hagin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
- (2021) Rabah Redjoul et al. LANCET
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
- (2021) Jason D Goldman et al. Journal for ImmunoTherapy of Cancer
- The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
- (2020) Per Ljungman et al. BONE MARROW TRANSPLANTATION
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- DCLRE1C(ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency
- (2015) Timo Volk et al. HUMAN MOLECULAR GENETICS
- HIV-associated chronic immune activation
- (2013) Mirko Paiardini et al. IMMUNOLOGICAL REVIEWS
- Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients
- (2013) Nathalie Dhédin et al. VACCINE
- Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals
- (2010) Pablo Tebas et al. AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now